These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24752773)

  • 1. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
    Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
    Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
    Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activation.
    Nie Y; Zhou L; Wang H; Chen N; Jia L; Wang C; Wang Y; Chen J; Wen X; Niu C; Li H; Guo R; Zhang S; Cui J; Hoffman AR; Hu JF; Li W
    Am J Cancer Res; 2019; 9(8):1635-1649. PubMed ID: 31497347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA RUNXOR Promotes Myeloid-Derived Suppressor Cell Expansion and Functions via Enhancing Immunosuppressive Molecule Expressions during Latent HIV Infection.
    Zhang J; Thakuri BKC; Zhao J; Nguyen LN; Nguyen LNT; Khanal S; Cao D; Dang X; Schank M; Lu Z; Wu XY; Morrison ZD; El Gazzar M; Jiang Y; Ning S; Wang L; Moorman JP; Yao ZQ
    J Immunol; 2021 May; 206(9):2052-2060. PubMed ID: 33820854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.
    Cheng CK; Wong THY; Wan TSK; Wang AZ; Chan NPH; Chan NCN; Li CK; Ng MHL
    Mol Cancer; 2018 Aug; 17(1):133. PubMed ID: 30157851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel long non-coding RNA within RUNX1 intron 5.
    Schnake N; Hinojosa M; Gutiérrez S
    Hum Genomics; 2019 Jul; 13(1):33. PubMed ID: 31366376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.
    Trinh BQ; Ummarino S; Zhang Y; Ebralidze AK; Bassal MA; Nguyen TM; Heller G; Coffey R; Tenen DE; van der Kouwe E; Fabiani E; Gurnari C; Wu CS; Angarica VE; Yang H; Chen S; Zhang H; Thurm AR; Marchi F; Levantini E; Staber PB; Zhang P; Voso MT; Pandolfi PP; Kobayashi SS; Chai L; Di Ruscio A; Tenen DG
    Blood; 2021 Oct; 138(15):1331-1344. PubMed ID: 33971010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer.
    Tian X; Ma J; Wang T; Tian J; Zheng Y; Peng R; Wang Y; Zhang Y; Mao L; Xu H; Wang S
    BMC Cancer; 2018 Jun; 18(1):660. PubMed ID: 29914443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3-miR124 Axis.
    Thakuri BKC; Zhang J; Zhao J; Nguyen LN; Nguyen LNT; Schank M; Khanal S; Dang X; Cao D; Lu Z; Wu XY; Jiang Y; El Gazzar M; Ning S; Wang L; Moorman JP; Yao ZQ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33353065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
    Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME; Hiebert SW
    Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
    Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
    Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.
    Oakford PC; James SR; Qadi A; West AC; Ray SN; Bert AG; Cockerill PN; Holloway AF
    Leuk Res; 2010 Sep; 34(9):1203-13. PubMed ID: 20439113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.